## Note
nid: 1509220336024
model: AnKingOverhaul
tags: #AK_Original_Decks::Step_1::Lolnotacop::Drugs, #AK_Step1_v11::#B&B::11_Hematology::04_Cancer_Drugs::02_Alkylating_Agents, #AK_Step1_v11::#FirstAid::10_Hematology_Oncology::05_Pharm::13_Alkylating_Agents, #AK_Step1_v11::#FirstAid::10_Hematology_Oncology::05_Pharm::13_Alkylating_Agents::Cyclophosphamide, #AK_Step1_v11::#FirstAid::10_Hematology_Oncology::05_Pharm::13_Alkylating_Agents::Ifosfamide, #AK_Step1_v11::#NBME::16, #AK_Step1_v11::#OME::06_Inflammation_Neoplasia::08_Cycle_Chemo, #AK_Step1_v11::#OME_banner::Clinical::05_Hematology_Oncology::06_Lymphoma, #AK_Step1_v11::#Pixorize::02_Biochem::22_Onc_Drugs::07_Cyclophosphamide,_Ifosfamide, #AK_Step1_v11::#SketchyPharm::08_Antineoplastics::02_Dna_&_Cellular_Division::01_Cyclophosphamide,_ifosfamide,_busulfan,_nitrosoureas_(carmustine,_lomustine,_streptozocin), #AK_Step1_v11::#UWorld::1000-9999::1000-1999::1816, #AK_Step2_v11::!Shelf::IM::no_dupes, #AK_Step2_v11::#OME::05_Heme_Onc::06_Lymphoma, #AK_Step2_v11::#Resources_by_rotation::IM::ome::heme/onc::lymphoma, #AK_Step2_v11::Original_decks::Dorian::im::ome::heme/onc::lymphoma
markdown: false

### Text
What drug can <u>bind acrolein</u> and <i>prevent</i>
<b>hemorrhagic cystitis</b> in cyclophosphamide, ifosfamide use?
<div>
  {{c1::<u>MESNA</u> (2-mercaptoethanesulfonate)}}
</div>

### Extra
<div>
  recall that acrolein is a toxic metabolite of -phosphamides
</div><img src="paste-70888435220873.jpg">

### Lecture Notes


### Missed Questions


### Pathoma


### Boards and Beyond


### First Aid
<img src="paste-183068686024707.jpg"><img src=
"paste-71386651426819.jpg">

### Sketchy
<img src="paste-359858129862657.jpg" class="resizer"><img src=
"paste-ad14b6d0922f1d7fd590079a8c8780ffd0ca15d3.png" class=
"resizer">

### Pixorize


### Physeo


### OME
<div class="ome-widget">
  <a href=
  "https://onlinemeded.org/spa/hematology-oncology/lymphoma/acquire?ref=anki">
  <img src="_OME_AnkiFlashcards_Lesson_3.png"></a>
</div>

### Additional Resources


### One by one

